4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-382277
Chief Operating Officer sold 10,000 shares at $208.65 ($2,086,500)
- Chief Operating Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jacobson Mark L. Chief Operating Officer | 2026-09-03 | Option exercise 10b5-1 | +10,000 | $12.95 | $129,500 | 10,000 | D: show line 1 in the form |
| Jacobson Mark L. Chief Operating Officer | 2026-09-03 | Sale 10b5-1 | −10,000 | $208.65 | $2,086,500 | 0 | D: show line 2 in the form |
| Open-market sales · 10,000 sh · avg $208.65 · $2,086,500 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Jacobson Mark L. Chief Operating Officer | 2026-09-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 104,954 | D: show line 3 in the form |
Loading xslF345X06/ownership.xml…